Literature DB >> 32470544

Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).

Hannah Siedel1, Axel Roers2, Angela Rösen-Wolff3, Hella Luksch1.   

Abstract

STING-associated vasculopathy with onset in infancy (SAVI) is an autoimmune disease caused by heterozygous gain of function mutations of STING (stimulator of interferon genes) that had initially been classified as a type I interferonopathy. We recently reported a genetically engineered mouse strain carrying a common SAVI-associated STING mutation. These STING N153S/WT mice reproduce key features of SAVI, including lung inflammation, loss of T cells in spleen and blood, splenomegaly and thymic hypoplasia. Here we show that αβ T lymphocytopenia is due to disrupted T cell development and is associated with impaired T cell activation and a relative increase in γδ T cell numbers. These alterations were not rescued by additional knockout of the type I IFN receptor (IFNAR1). Collectively, our findings consolidate the concept that constitutive STING signalling leads to a SCID-like phenotype in STING N153S/WT mice.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32470544     DOI: 10.1016/j.clim.2020.108466

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

1.  The cGAS-STING Pathway Affects Vertebral Bone but Does Not Promote Intervertebral Disc Cell Senescence or Degeneration.

Authors:  Olivia K Ottone; Cheeho Kim; John A Collins; Makarand V Risbud
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

Review 2.  Intracellular Sensing of DNA in Autoinflammation and Autoimmunity.

Authors:  Susan MacLauchlan; Katherine A Fitzgerald; Ellen M Gravallese
Journal:  Arthritis Rheumatol       Date:  2022-09-06       Impact factor: 15.483

Review 3.  STING-Mediated Lung Inflammation and Beyond.

Authors:  Marie-Louise Frémond; Yanick J Crow
Journal:  J Clin Immunol       Date:  2021-02-02       Impact factor: 8.317

Review 4.  The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities.

Authors:  Jiaqi Lin; Jinxuan Ren; Dave Schwinn Gao; Yi Dai; Lina Yu
Journal:  Front Chem       Date:  2021-05-12       Impact factor: 5.221

Review 5.  The cGAS-STING pathway as a therapeutic target in inflammatory diseases.

Authors:  Alexiane Decout; Jason D Katz; Shankar Venkatraman; Andrea Ablasser
Journal:  Nat Rev Immunol       Date:  2021-04-08       Impact factor: 53.106

6.  The transmembrane endoplasmic reticulum-associated E3 ubiquitin ligase TRIM13 restrains the pathogenic-DNA-triggered inflammatory response.

Authors:  Xuelian Li; Zhou Yu; Qian Fang; Mingjin Yang; Jiaying Huang; Zheng Li; Jianli Wang; Taoyong Chen
Journal:  Sci Adv       Date:  2022-01-26       Impact factor: 14.136

Review 7.  Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases.

Authors:  Rebecca L Harper; Elisa A Ferrante; Manfred Boehm
Journal:  Semin Immunopathol       Date:  2022-03-01       Impact factor: 11.759

Review 8.  Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).

Authors:  Clémence David; Marie-Louise Frémond
Journal:  Cells       Date:  2022-01-18       Impact factor: 6.600

9.  COPA silences STING.

Authors:  Sophie Rivara; Andrea Ablasser
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

Review 10.  The cGAS-STING Pathway: A Promising Immunotherapy Target.

Authors:  Liang Ou; Ao Zhang; Yuxing Cheng; Ying Chen
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.